Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb
文献类型:期刊论文
作者 | Xin Zhao1; Xiao-Xu Yang2; Su-Zhen Ji1; Xiao-Zeng Wang1; Li Wang1; Chong-Huai Gu1; Li-Li Ren1; Ya-Ling Han1 |
刊名 | Military Medical Research
![]() |
出版日期 | 2016 |
卷号 | 3期号:1 |
ISSN号 | 2054-9369 |
其他题名 | Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb |
英文摘要 | In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incidence of bleeding. Therefore, drugs with stable anticoagulant effects are urgently required. |
语种 | 英语 |
源URL | [http://ir.imr.ac.cn/handle/321006/159370] ![]() |
专题 | 金属研究所_中国科学院金属研究所 |
作者单位 | 1.Institute of Metal Research, Chinese Academy of Sciences 2.沈阳医学院 |
推荐引用方式 GB/T 7714 | Xin Zhao,Xiao-Xu Yang,Su-Zhen Ji,et al. Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb[J]. Military Medical Research,2016,3(1). |
APA | Xin Zhao.,Xiao-Xu Yang.,Su-Zhen Ji.,Xiao-Zeng Wang.,Li Wang.,...&Ya-Ling Han.(2016).Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb.Military Medical Research,3(1). |
MLA | Xin Zhao,et al."Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb".Military Medical Research 3.1(2016). |
入库方式: OAI收割
来源:金属研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。